Trial Profile
A retrospective study to evaluate the alterations of hematogenesis and bone mineral density after dutasteride treatment in aged patients with benign prostatic hyperplasia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 18 Aug 2015 New trial record